Volitionrx (VNRX) Return on Capital Employed (2013 - 2026)
Volitionrx's (VNRX) quarterly Return on Capital Employed came in at 391.29% in Q4 2025, up 122305.0% YoY from N/an in Q4 2024, and down 33.72% on a QoQ basis from 590.4% in Q3 2025.
Volitionrx (VNRX) Return on Capital Employed (2013 - 2026) Analysis & Trends
Volitionrx (VNRX) has 8 years of Return on Capital Employed data on file, last reported at 391.29% in Q4 2025.
- Quarterly Return on Capital Employed rose 122305.0% year-over-year to 391.29% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 391.29% (up 122305.0% YoY) and the FY2025 annual result came in at 532.76%, up 78105.0% from the prior year.
- Return on Capital Employed fell to 391.29% in Q4 2025, from 590.4% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 3734.49% in Q2 2025 to a low of 3559.03% in Q1 2023.
- A 5-year average of 351.25% and a median of 251.97% in 2022 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 401196 bps — and 2025, when it tumbled 397157 bps.
- Tracing VNRX's Return on Capital Employed over 5 years: stood at 127.45% in 2021, then plunged by 627 bps to 925.96% in 2022, then soared by 72 bps to 256.1% in 2023, then sank by 225 bps to 831.76% in 2024, then surged by 147 bps to 391.29% in 2025.
- The last three Return on Capital Employed figures came in at 391.29% (Q4 2025), 590.4% (Q3 2025), and 3734.49% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Volitionrx | 1.19 Mn | -1.60 Mn | - | 345.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 345.80% |
| Dec 31, 2025 | 391.29% |
| Sep 30, 2025 | 590.40% |
| Jun 30, 2025 | 3,734.49% |
| Mar 31, 2025 | -3,518.64% |
| Dec 31, 2024 | -831.76% |
| Sep 30, 2024 | 172.27% |
| Jun 30, 2024 | 222.55% |
| Mar 31, 2024 | 452.93% |
| Dec 31, 2023 | -256.10% |
| Sep 30, 2023 | -685.05% |
| Jun 30, 2023 | -865.02% |
| Mar 31, 2023 | -3,559.03% |
| Dec 31, 2022 | -925.96% |
| Sep 30, 2022 | -474.13% |
| Jun 30, 2022 | -301.22% |
| Mar 31, 2022 | -247.84% |
| Dec 31, 2021 | -127.45% |
| Sep 30, 2021 | -94.16% |
| Mar 31, 2020 | -123.87% |